ExodusPoint Capital Management, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$887
-78.7%
10,423
-79.3%
0.01%
-79.4%
Q1 2023$4,157
+39.4%
50,232
+32.5%
0.03%
-20.9%
Q4 2022$2,981
-99.0%
37,900
+561.9%
0.04%
+1333.3%
Q4 2021$304,000
-54.5%
5,726
-4.8%
0.00%
-70.0%
Q1 2021$668,000
-85.4%
6,015
-84.4%
0.01%
-77.8%
Q4 2020$4,570,000
-27.9%
38,488
-47.0%
0.04%
-64.6%
Q3 2020$6,339,000
+84.3%
72,659
+89.2%
0.13%
+42.7%
Q2 2020$3,439,000
-10.5%
38,401
+14.8%
0.09%
+23.6%
Q4 2019$3,842,00033,4370.07%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders